The diabetes testing product maker’s $86.8m Arkray 4U unit will seek out strategic entrepreneurs for its parent in areas such as digital medical equipment and functional food.

Japan-headquartered healthcare device producer Arkray has announced a ¥10bn ($86.8m) Singapore-based corporate venture capital initiative launched in a bid to back early-stage medical technology developers.

Formed in November 2021, Arkray 4U will invest directly from its parent firm’s balance sheet as opposed to a dedicated fund, Arkray 4U senior investment associate Wei Cong Seah told DealStreetAsia. It expects to provide up to $2.6m per deal.

Seah said the team is involved in the due diligence process for multiple startups but…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?
Edison Fu

Edison Fu is a reporter and Asia liaison at Global Corporate Venturing.